Depression Drugs Market is expected to grow at a CAGR of 3 6% during the forecast period - Exclusive Report by Proficient Market sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.
Cadila Healthcare gained 1.97% to Rs 442.45 after the drug maker said it received a final approval from the US drug regulator to market nortriptyline hydrochloride capsules 10 mg, 25 mg, 50 mg and 75 mg.The medication is used to treat mental/mood problems such as depression. The drug will be manufactured at the group s formulation manufacturing facility at the SEZ, Ahmedabad.
The group now has 313 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
Separately, Cadila Healthcare announced that its US subsidiary has acquired experimental drug from Cyprium for treating Menkes disease. Cyprium Therapeutics, a partner of Fortress Biotech, and Sentynl Therapeutics, a US- based specialty pharmaceutical company owned by the Zydus Group, has announced its execution of an asset purchase agreement to commit development funding for and acquire Cyprium s proprietary rights to CUTX-101, its Copper Histidinate product candidate for the treatme
This medication is used to treat mental/mood problems such as depression.
It may help improve mood
and feelings of well-being, relieve anxiety and tension, and increase one s energy level. The drug will
be manufactured at the group s formulation manufacturing facility at the SEZ, Ahmedabad.
The group now has 313 approvals and has so far filed over 400 ANDAs since the commencement of
the filing process in FY 2003-04.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.) Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Co
Databridgemarketresearch.com Present “
Global Sciatica Treatment Market– Industry Trends and Forecast to 2027” new report to its research database. This
Global Sciatica Treatment Market report provides explanation about the detailed market analysis with inputs from industry experts. Competitive landscape in this report covers strategic profiling of key players in the market, comprehensively analyzing their core competencies, and strategies. The data and information regarding the industry are taken from trustworthy sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the market experts. Gaining valuable market insights with the new skills, latest tools and innovative programs is sure to help your business achieve business goals.
Global Postpartum Depression Therapeutics Market 2020 Growth Factors, Product Overview, Segmentation and Forecast Study to 2025 marketwatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketwatch.com Daily Mail and Mail on Sunday newspapers.